H

ello, everyone, and welcome to Tuesday. STAT reporter Rebecca Robbins here again, delivering your morning headlines from a Boston satellite of the currently vacationing Pharmalot campus. It’s a bit cloudy here — made brighter, we admit, by an iced chai latte and some freshly picked blueberries. As always, if you come across an interesting tidbit in the world of pharma today, do let us know.

New Hampshire’s second largest city, Nashua, is considering joining the growing wave of state and local governments that have filed lawsuits accusing drug makers of fueling the opioid crisis, the New Hampshire Union Leader reports. The state’s largest city, Manchester, has also reportedly agreed to join Nashua’s potential case, which would seek damages incurred by the municipality as a result of over-prescribing of opioids.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy